FDA Issues Warning Over Ketamine Misuse, DEA Extends Telemedicine Flexibilities

The Food and Drug Administration (FDA) issued an alert on the dangers of self-treating psychiatric disorders with unapproved compounded versions of ketamine and ketamine-based drugs whether modified or tailored for specific patient needs. In view of the anesthetic’s rising popularity as an…#fda #anesthesia #harvard #dea #hhs #poptika #shutterstock
Source: Reuters: Health - Category: Consumer Health News Source Type: news